HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Renal-Protective Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone in ob/ob Mice.

Abstract
BACKGROUND This study investigated the therapeutic effects of the peroxisome proliferator-activated receptor-γ (PPARγ) agonist pioglitazone in ob/ob mice with obesity-related glomerulopathy (ORG). MATERIAL AND METHODS A total of 24 mice were divided into 3 groups: wild-type C57BL/6 mice (n=8), ob/ob mice (n=8), and ob/ob mice receiving pioglitazone treatment (n=8). Body mass, blood glucose, serum adiponectin (ADP), and urine microalbumin (mALB) levels were determined. Renal histology was examined using light and electron microscopy. Wilms tumor 1 (WT1), Zonula occludens-1 (ZO-1), AMP activated protein kinase (AMPK), and NADPH oxidase-4 (NOX-4) expression were evaluated by immunohistochemistry and Western blot. RESULTS Serum ADP did not alter between weeks 0 and 12 in the control group, while the ob/ob mice showed a time-dependent decrease that was prevented by pioglitazone. Urinary mALB did not alter between week 0 and 12 in the control group, but was higher in week 0 and week 12 in the ob/ob group. Pioglitazone prevented the rise in urinary mALB in week 12. Histology revealed glomerulomegaly, mesangial proliferation, focal segmental glomerulosclerosis, and foot processes fusion in the ob/ob group, which were ameliorated by pioglitazone treatment. Compared to the control group, ob/ob mice had a higher kidney index and glomerular diameter, which were reduced by pioglitazone treatment. Immunohistochemical and Western blot experiments revealed lower expression levels of WT1, ZO-1, and AMPK and higher NOX-4 expression level in the ob/ob group, which was prevented by pioglitazone treatment. CONCLUSIONS Pioglitazone, a PPARγ agonist, can prevent ORG, probably by reducing oxidative stress.
AuthorsYing Li, Tian Xia, Rong Li, Gary Tse, Tong Liu, Guangping Li
JournalMedical science monitor : international medical journal of experimental and clinical research (Med Sci Monit) Vol. 25 Pg. 1582-1589 (Mar 01 2019) ISSN: 1643-3750 [Electronic] United States
PMID30820023 (Publication Type: Journal Article)
Chemical References
  • Adiponectin
  • Blood Glucose
  • Hypoglycemic Agents
  • PPAR gamma
  • Serum Albumin
  • Thiazolidinediones
  • Pioglitazone
Topics
  • Adiponectin (analysis, blood)
  • Animals
  • Blood Glucose
  • Glomerulonephritis, Membranous (metabolism)
  • Hypoglycemic Agents
  • Kidney (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Obesity (metabolism)
  • Oxidative Stress
  • PPAR gamma (agonists, metabolism)
  • Pioglitazone (metabolism, pharmacology)
  • Serum Albumin (analysis)
  • Thiazolidinediones

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: